The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of presence of any mucinous component in curatively resected stage II and III colorectal cancer patients who received adjuvant treatments: Data from a single tertiary center.
Faysal Dane
No relevant relationships to disclose
Mehmet Akif Ozturk
No relevant relationships to disclose
Perran Fulden Yumuk
No relevant relationships to disclose
Muharrem Kocar
No relevant relationships to disclose
Mehmet Besiroglu
No relevant relationships to disclose
Beste Melek Atasoy
No relevant relationships to disclose
Ferhat Telli
No relevant relationships to disclose
Metin Kanitez
No relevant relationships to disclose
Bilge Aktas
No relevant relationships to disclose
Nazim S. Turhal
No relevant relationships to disclose